Skip to content
4 things to know during C. diff Awareness Month
When Peggy Lillis was put on an antibiotic to treat an abscess after a root canal, her family had no idea of what was […]
4 things to know during C. diff Awareness Month Read More »
Latest News
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit
As biotech breakthroughs enable remarkable advances in treatment and prevention of disease, we need similar levels of innovation in access, so patients benefit from
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit Read More »
BIO to present biotech’s benefits for climate and food at COP29
As the world gathers in Baku, Azerbaijan, for the COP29 United Nations Climate Summit, the Biotechnology Innovation Organization (BIO) is ensuring biotech’s role in
BIO to present biotech’s benefits for climate and food at COP29 Read More »
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply
Biotech apples designed to last longer, taste great, and make superior cider were the stars when Rep. Dan Newhouse (R-WA) toured Okanagan Specialty Fruits’
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply Read More »
MAPRx is helping patients navigate open enrollment
It is open enrollment season for Medicare Part D, and the patient-led advocacy coalition MAPRx is helping patients get the coverage they need. Open
MAPRx is helping patients navigate open enrollment Read More »
BIO explains drug development process in California Supreme Court brief supporting Gilead
Drugmakers dealing with the complex process of developing medicines must be allowed to decide against trying to bring a drug to market, the Biotechnology
BIO makes recommendation for new FDA Rare Disease Innovation Hub
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With the goal of engaging
BIO makes recommendation for new FDA Rare Disease Innovation Hub Read More »
CMS must address Part D plan abuse of IRA provisions designed to protect patient access
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for Medicare & Medicaid Services (CMS) take steps to protect patient access,
CMS must address Part D plan abuse of IRA provisions designed to protect patient access Read More »
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
CPAC supports FTC action against pharmacy benefit managers
Despite frequent criticism of the Federal Trade Commission (FTC), the Conservative Political Action Conference (CPAC) has announced its support for FTC efforts to rein in pharmacy
CPAC supports FTC action against pharmacy benefit managers Read More »